Studies have shown that COVID-19 patients often exhibit significant lymphocytopenia, particularly a decrease in CD4+ and CD8+ T lymphocytes, which are crucial for mounting an effective immune response against TB [3]. This evidence concerns the gene CD4 and COVID-19.